Peptide Therapeutics Market Report: Trends, Forecast and Competitive Analysis to 2030
Get it in 2 to 4 weeks by ordering today
Peptide Therapeutics Trends and Forecast
The future of the global peptide therapeutics market looks promising with opportunities in the cancer, metabolic disorder, cardiovascular disorder, respiratory disorder, gastrointestinal disorder, infectious disease, pain, dermatological disorder, neurological disorder, and renal disorder markets. The global peptide therapeutics market is expected to reach an estimated $55.5 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are the rising frequency of cancer and metabolic diseases such as osteoporosis, obesity, and diabetes, increased need for effective and quick-acting treatments, and advancement in peptide manufacturing techniques.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Peptide Therapeutics by Segment
The study includes a forecast for the global peptide therapeutics by type, route of administration, manufacturing, application, and region.
Peptide Therapeutics Market by Type [Shipment Analysis by Value from 2018 to 2030]:
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies peptide therapeutics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the peptide therapeutics companies profiled in this report include-
Lucintel forecasts that innovative will remain the larger segment over the forecast period due to significant R&D spending in the research and development of new treatments by big pharmaceutical corporations, as well as high prescription rates.
North America will remain the largest region over the forecast period due to the introduction of efficient products as well as technologically sophisticated manufacturing facilities throughout the region.
Features of the Global Peptide Therapeutics Market
Market Size Estimates: Peptide therapeutics market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Peptide therapeutics market size by type, route of administration, manufacturing, application, and region in terms of value ($B).
Regional Analysis: Peptide therapeutics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different type, route of administration, manufacturing, application, and regions for the peptide therapeutics market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the peptide therapeutics market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the peptide therapeutics market size?
Answer: The global peptide therapeutics market is expected to reach an estimated $55.5 billion by 2030.
Q2. What is the growth forecast for peptide therapeutics market?
Answer: The global peptide therapeutics market is expected to grow with a CAGR of 6.5% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the peptide therapeutics market?
Answer: The major drivers for this market are the rising frequency of cancer and metabolic diseases such as osteoporosis, obesity, and diabetes, increased need for effective and quick-acting treatments, and advancement in peptide manufacturing techniques.
Q4. What are the major segments for peptide therapeutics market?
Answer: The future of the global peptide therapeutics market looks promising with opportunities in the cancer, metabolic disorder, cardiovascular disorder, respiratory disorder, gastrointestinal disorder, infectious disease, pain, dermatological disorder, neurological disorder, and renal disorder markets.
Q5. Who are the key peptide therapeutics market companies?
Answer: Some of the key peptide therapeutics companies are as follows:
Answer: Lucintel forecasts that innovative will remain the larger segment over the forecast period due to significant R&D spending in the research and development of new treatments by big pharmaceutical corporations, as well as high prescription rates.
Q7. In peptide therapeutics market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to the introduction of efficient products as well as technologically sophisticated manufacturing facilities throughout the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the peptide therapeutics market by type (generic and innovative), route of administration (parenteral route, oral route, pulmonary, mucosal, and others), manufacturing (in-house and outsourced), application (cancer, metabolic disorder, cardiovascular disorder, respiratory disorder, gastrointestinal disorder, infectious diseases, pain, dermatological disorder, neurological disorder, and renal disorder), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Peptide Therapeutics Market, Peptide Therapeutics Market Size, Peptide Therapeutics Market Growth, Peptide Therapeutics Market Analysis, Peptide Therapeutics Market Report, Peptide Therapeutics Market Share, Peptide Therapeutics Market Trends, Peptide Therapeutics Market Forecast, Peptide Therapeutics Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
Peptide Therapeutics Trends and Forecast
The future of the global peptide therapeutics market looks promising with opportunities in the cancer, metabolic disorder, cardiovascular disorder, respiratory disorder, gastrointestinal disorder, infectious disease, pain, dermatological disorder, neurological disorder, and renal disorder markets. The global peptide therapeutics market is expected to reach an estimated $55.5 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are the rising frequency of cancer and metabolic diseases such as osteoporosis, obesity, and diabetes, increased need for effective and quick-acting treatments, and advancement in peptide manufacturing techniques.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Peptide Therapeutics by Segment
The study includes a forecast for the global peptide therapeutics by type, route of administration, manufacturing, application, and region.
Peptide Therapeutics Market by Type [Shipment Analysis by Value from 2018 to 2030]:
- Generic
- Innovative
- Parenteral Route
- Oral Route
- Pulmonary
- Mucosal
- Others
- In-House
- Outsourced
- Cancer
- Metabolic Disorder
- Cardiovascular Disorder
- Respiratory Disorder
- Gastrointestinal Disorder
- Infectious Diseases
- Pain
- Dermatological Disorder
- Neurological Disorder
- Renal Disorder
- North America
- Europe
- Asia Pacific
- The Rest of the World
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies peptide therapeutics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the peptide therapeutics companies profiled in this report include-
- Eli Lilly and Company
- Pfizer
- Amgen
- Takeda Pharmaceutical Company
- AstraZeneca
- Teva Pharmaceutical Industries
- Sanofi
- F. Hoffmann-La Roche
- Novartis
- Novo Nordisk
Lucintel forecasts that innovative will remain the larger segment over the forecast period due to significant R&D spending in the research and development of new treatments by big pharmaceutical corporations, as well as high prescription rates.
North America will remain the largest region over the forecast period due to the introduction of efficient products as well as technologically sophisticated manufacturing facilities throughout the region.
Features of the Global Peptide Therapeutics Market
Market Size Estimates: Peptide therapeutics market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Peptide therapeutics market size by type, route of administration, manufacturing, application, and region in terms of value ($B).
Regional Analysis: Peptide therapeutics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different type, route of administration, manufacturing, application, and regions for the peptide therapeutics market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the peptide therapeutics market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the peptide therapeutics market size?
Answer: The global peptide therapeutics market is expected to reach an estimated $55.5 billion by 2030.
Q2. What is the growth forecast for peptide therapeutics market?
Answer: The global peptide therapeutics market is expected to grow with a CAGR of 6.5% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the peptide therapeutics market?
Answer: The major drivers for this market are the rising frequency of cancer and metabolic diseases such as osteoporosis, obesity, and diabetes, increased need for effective and quick-acting treatments, and advancement in peptide manufacturing techniques.
Q4. What are the major segments for peptide therapeutics market?
Answer: The future of the global peptide therapeutics market looks promising with opportunities in the cancer, metabolic disorder, cardiovascular disorder, respiratory disorder, gastrointestinal disorder, infectious disease, pain, dermatological disorder, neurological disorder, and renal disorder markets.
Q5. Who are the key peptide therapeutics market companies?
Answer: Some of the key peptide therapeutics companies are as follows:
- Eli Lilly and Company
- Pfizer
- Amgen
- Takeda Pharmaceutical Company
- AstraZeneca
- Teva Pharmaceutical Industries
- Sanofi
- F. Hoffmann-La Roche
- Novartis
- Novo Nordisk
Answer: Lucintel forecasts that innovative will remain the larger segment over the forecast period due to significant R&D spending in the research and development of new treatments by big pharmaceutical corporations, as well as high prescription rates.
Q7. In peptide therapeutics market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to the introduction of efficient products as well as technologically sophisticated manufacturing facilities throughout the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the peptide therapeutics market by type (generic and innovative), route of administration (parenteral route, oral route, pulmonary, mucosal, and others), manufacturing (in-house and outsourced), application (cancer, metabolic disorder, cardiovascular disorder, respiratory disorder, gastrointestinal disorder, infectious diseases, pain, dermatological disorder, neurological disorder, and renal disorder), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Peptide Therapeutics Market, Peptide Therapeutics Market Size, Peptide Therapeutics Market Growth, Peptide Therapeutics Market Analysis, Peptide Therapeutics Market Report, Peptide Therapeutics Market Share, Peptide Therapeutics Market Trends, Peptide Therapeutics Market Forecast, Peptide Therapeutics Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
1. EXECUTIVE SUMMARY
2. GLOBAL PEPTIDE THERAPEUTICS MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Peptide Therapeutics Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Peptide Therapeutics Market by Type
3.3.1: Generic
3.3.2: Innovative
3.4: Global Peptide Therapeutics Market by Route of Administration
3.4.1: Parenteral Route
3.4.2: Oral Route
3.4.3: Pulmonary
3.4.4: Mucosal
3.4.5: Others
3.5: Global Peptide Therapeutics Market by Manufacturing
3.5.1: In-house
3.5.2: Outsourced
3.6: Global Peptide Therapeutics Market by Application
3.6.1: Cancer
3.6.2: Metabolic Disorder
3.6.3: Cardiovascular Disorder
3.6.4: Respiratory Disorder
3.6.5: Gastrointestinal Disorder
3.6.6: Infectious Diseases
3.6.7: Pain
3.6.8: Dermatological Disorder
3.6.9: Neurological Disorder
3.6.10: Renal Disorder
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Peptide Therapeutics Market by Region
4.2: North American Peptide Therapeutics Market
4.2.1: North American Peptide Therapeutics Market by Type: Generic and Innovative
4.2.2: North American Peptide Therapeutics Market by Application: Cancer, Metabolic Disorder, Cardiovascular Disorder, Respiratory Disorder, Gastrointestinal Disorder, Infectious Diseases, Pain, Dermatological Disorder, Neurological Disorder, and Renal Disorder
4.3: European Peptide Therapeutics Market
4.3.1: European Peptide Therapeutics Market by Type: Generic and Innovative
4.3.2: European Peptide Therapeutics Market by Application: Cancer, Metabolic Disorder, Cardiovascular Disorder, Respiratory Disorder, Gastrointestinal Disorder, Infectious Diseases, Pain, Dermatological Disorder, Neurological Disorder, and Renal Disorder
4.4: APAC Peptide Therapeutics Market
4.4.1: APAC Peptide Therapeutics Market by Type: Generic and Innovative
4.4.2: APAC Peptide Therapeutics Market by Application: Cancer, Metabolic Disorder, Cardiovascular Disorder, Respiratory Disorder, Gastrointestinal Disorder, Infectious Diseases, Pain, Dermatological Disorder, Neurological Disorder, and Renal Disorder
4.5: ROW Peptide Therapeutics Market
4.5.1: ROW Peptide Therapeutics Market by Type: Generic and Innovative
4.5.2: ROW Peptide Therapeutics Market by Application: Cancer, Metabolic Disorder, Cardiovascular Disorder, Respiratory Disorder, Gastrointestinal Disorder, Infectious Diseases, Pain, Dermatological Disorder, Neurological Disorder, and Renal Disorder
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Peptide Therapeutics Market by Type
6.1.2: Growth Opportunities for the Global Peptide Therapeutics Market by Route of Administration
6.1.3: Growth Opportunities for the Global Peptide Therapeutics Market by Manufacturing
6.1.4: Growth Opportunities for the Global Peptide Therapeutics Market by Application
6.1.5: Growth Opportunities for the Global Peptide Therapeutics Market by Region
6.2: Emerging Trends in the Global Peptide Therapeutics Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Peptide Therapeutics Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Peptide Therapeutics Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Eli Lilly and Company
7.2: Pfizer
7.3: Amgen
7.4: Takeda Pharmaceutical Company
7.5: AstraZeneca
7.6: Teva Pharmaceutical Industries
7.7: Sanofi
7.8: F. Hoffmann-La Roche
7.9: Novartis
7.10: Novo Nordisk
2. GLOBAL PEPTIDE THERAPEUTICS MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Peptide Therapeutics Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Peptide Therapeutics Market by Type
3.3.1: Generic
3.3.2: Innovative
3.4: Global Peptide Therapeutics Market by Route of Administration
3.4.1: Parenteral Route
3.4.2: Oral Route
3.4.3: Pulmonary
3.4.4: Mucosal
3.4.5: Others
3.5: Global Peptide Therapeutics Market by Manufacturing
3.5.1: In-house
3.5.2: Outsourced
3.6: Global Peptide Therapeutics Market by Application
3.6.1: Cancer
3.6.2: Metabolic Disorder
3.6.3: Cardiovascular Disorder
3.6.4: Respiratory Disorder
3.6.5: Gastrointestinal Disorder
3.6.6: Infectious Diseases
3.6.7: Pain
3.6.8: Dermatological Disorder
3.6.9: Neurological Disorder
3.6.10: Renal Disorder
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Peptide Therapeutics Market by Region
4.2: North American Peptide Therapeutics Market
4.2.1: North American Peptide Therapeutics Market by Type: Generic and Innovative
4.2.2: North American Peptide Therapeutics Market by Application: Cancer, Metabolic Disorder, Cardiovascular Disorder, Respiratory Disorder, Gastrointestinal Disorder, Infectious Diseases, Pain, Dermatological Disorder, Neurological Disorder, and Renal Disorder
4.3: European Peptide Therapeutics Market
4.3.1: European Peptide Therapeutics Market by Type: Generic and Innovative
4.3.2: European Peptide Therapeutics Market by Application: Cancer, Metabolic Disorder, Cardiovascular Disorder, Respiratory Disorder, Gastrointestinal Disorder, Infectious Diseases, Pain, Dermatological Disorder, Neurological Disorder, and Renal Disorder
4.4: APAC Peptide Therapeutics Market
4.4.1: APAC Peptide Therapeutics Market by Type: Generic and Innovative
4.4.2: APAC Peptide Therapeutics Market by Application: Cancer, Metabolic Disorder, Cardiovascular Disorder, Respiratory Disorder, Gastrointestinal Disorder, Infectious Diseases, Pain, Dermatological Disorder, Neurological Disorder, and Renal Disorder
4.5: ROW Peptide Therapeutics Market
4.5.1: ROW Peptide Therapeutics Market by Type: Generic and Innovative
4.5.2: ROW Peptide Therapeutics Market by Application: Cancer, Metabolic Disorder, Cardiovascular Disorder, Respiratory Disorder, Gastrointestinal Disorder, Infectious Diseases, Pain, Dermatological Disorder, Neurological Disorder, and Renal Disorder
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Peptide Therapeutics Market by Type
6.1.2: Growth Opportunities for the Global Peptide Therapeutics Market by Route of Administration
6.1.3: Growth Opportunities for the Global Peptide Therapeutics Market by Manufacturing
6.1.4: Growth Opportunities for the Global Peptide Therapeutics Market by Application
6.1.5: Growth Opportunities for the Global Peptide Therapeutics Market by Region
6.2: Emerging Trends in the Global Peptide Therapeutics Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Peptide Therapeutics Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Peptide Therapeutics Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Eli Lilly and Company
7.2: Pfizer
7.3: Amgen
7.4: Takeda Pharmaceutical Company
7.5: AstraZeneca
7.6: Teva Pharmaceutical Industries
7.7: Sanofi
7.8: F. Hoffmann-La Roche
7.9: Novartis
7.10: Novo Nordisk
